Log in
Enquire now
‌

US Patent 9682080 Pyruvate kinase activators for use in therapy

Patent 9682080 was granted and assigned to Agios Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Agios Pharmaceuticals
Agios Pharmaceuticals
0
Current Assignee
Agios Pharmaceuticals
Agios Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96820800
Patent Inventor Names
Shin-San Michael Su0
Date of Patent
June 20, 2017
0
Patent Application Number
148867500
Date Filed
October 19, 2015
0
Patent Citations Received
‌
US Patent 11866411 Therapeutic compounds and compositions
0
‌
US Patent RE49582 Therapeutic compounds and compositions
0
Patent Primary Examiner
‌
Raymond Henley, III
0
Patent abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9682080 Pyruvate kinase activators for use in therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.